ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 657305 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 657305; 2) Community: the network communities that were significantly associated with the response to NSC 657305; 3) Molecule: the relationships between components within communities and NSC 657305; 4) MDR: the compounds that were significantly associated with the NSC 657305.

NSC Compound Enrichment Correlation
NSC 710716 Null 0.0414190425892865 0.13955813
NSC 720297 Methyl-7.alpha.,12.alpha.-diacetoxy-5.beta.-cholan-24-oate~ -3-spiro-6'-(1',2',4',5'-tetraoxacyclohexane)-3'-spiro-1"-(4"-t-butyl)cyclohexane 0.0414190425892865 0.21739822
NSC 720447 Null 0.0414190425892865 -0.1108333
NSC 721049 7Z-Plakortide H 0.0414190425892865 0.088579127
NSC 726267 Null 0.0414190425892865 0.2695615
NSC 728035 1N-{2-[7-methoxy-5-oxo-(11aS)-2,3,5,11a-tetrahydro-1H-benzo[ e]pyrrolo[1,2-a][1,4]diazepin-8-yloxy]ethyl}-2-[8-benzyloxy- 7-methoxy-5-oxo-(11aS)-2,3,5,11a-tetrahydro-1H-benzo[e]pyrro lo[1,2-a][1,4]di 0.0414190425892865 0.29511942
NSC 733467 Null 0.0414190425892865 0.24887273
NSC 733504 Everolimus 0.0414190425892865 0.051443447
NSC 740 Methotrexate 0.0414190425892865 0.041712489
NSC 763059 Paracymene-ruthenium(II)-[N-(3-(1H-imidazol-1-yl)propyl)-4-(1-(3,5,5,8,8-pentamethyl-5,6,7,8 tetrahydronaphthalen-2-yl)vinyl)benzamide] dichloride 0.0414190425892865 -0.12157562
Total:71  Current:62    [First] [Prev] [Next] [Last]